Simbajon, Kimberly S.
HRN: 27-74-73 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2025
CEFUROXIME 750MG (VIAL)
09/04/2025
09/10/2025
IV
750mg
Q8
UTI
Checking Initial Appropriateness
09/04/2025
CEFUROXIME 500MG (TAB)
09/04/2025
09/12/2025
PO
500mg
BID
PROM X 11 Hours
Checking Initial Appropriateness